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ABSTRACT
At the beginning of 2020, one of the most significant health problems for 
humanity is the pandemic of coronavirus disease 2019 (COVID-19). Here, 
we identify features and develop simple epidemic model of COVID-19 on 
the basis of available epidemiological data and existing trends worldwide. 
Modeling of COVID-19 epidemic process was based on a classic model. A key 
parameter of the model, i.e. transmission parameter of severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2), was determined numerically with the 
use of available epidemiological daily reports of COVID-19 from 17 April to 
23 May 2020. Numerical determination of transmission parameter of SARS-
CoV-2 according to the absolute number of COVID-19 cases in Ukraine, 
Indonesia and worldwide data showed its global tendency to decrease over 
time. Approximation of the obtained numerical values of the transmission 
parameter of SARS-CoV-2 was carried out using the exponential function. The 
results of prognostic modeling showed that by the end of summer 2020, above 
30 thousand COVID-19 cases are expected in Ukraine, 100 thousand COVID-19 
cases in Indonesia, and 12 million COVID-19 cases worldwide. Thus, predicting 
the possible consequences of the implementation of various health care control 
programs COVID-19 involves a comprehensive study of the epidemic process 
of the disease as a whole and for certain periods of time with the subsequent 
construction of an adequate prediction model. 
ABSTRAK
Pada awal tahun 2020, salah satu masalah utama kesehatan masyarakat di 
dunia adalah epidemi coronavirus disease 2019 (COVID-19). Dalam studi ini, 
kami mengidentifikasi karakteristik dan mengembangkan model epidemi 
sederhana berdasarkan data epidemiologis yang tersedia. Permodelan epidemi 
COVID-19 dibuat berdasarkan model klasik. Parameter utama model tersebut, 
yaitu parameter transmisi severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2), ditentukan secara numerik berdasarkan data epidemiologis 
laporan kasus harian COVID-19 dari tanggal 17 April sampai dengan 23 Mei 
2020. Penentuan parameter transmisi secara numerik berdasarkan jumlah 
absolut kasus COVID-19 di Ukraina, Indonesia, dan dunia menunjukkan adanya 
tren penurunan kasus. Hasil dari permodelan prognostik menunjukkan bahwa 
pada akhir musim panas tahun 2020, diperkirakan terdapat 30 ribu kasus 
di Ukraina, 100 ribu kasus di Indonesia, dan 12 juta kasus di seluruh dunia. 
Jadi, memprediksi hasil dari langkah-langkah kebijakan untuk menghentikan 
dan mengontrol pandemi COVID-19 memerlukan analisis yang komprehensif 
berkaitan dengan bagaimana perjalanan pandemi secara keseluruhan dan 
pada rentang waktu tertentu, diikuti dengan permodelan prediksi yang sesuai.
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INTRODUCTION
The role of viruses is constantly 
growing in the occurrence and 
development of infectious diseases 
of the human respiratory system. At 
the beginning of 21st century, 11 new 
respiratory viruses were discovered, that 
can cause severe respiratory diseases, 
often with fatal outcome. Among them 
are new human coronaviruses, severe 
acute respiratory syndrome coronavirus 
(SARS-CoV) and middle east respiratory 
syndrome coronavirus (MERS-CoV). Both 
of them cause acute respiratory diseases 
with high mortality rates. Since the 
discovery of SARS in 2002 and then MERS 
in 2012, the World Health Organization 
(WHO) experts have significantly 
increased epidemic safety against 
pathogens of these serious human 
diseases, and intensive studies of new 
members of the family Coronaviridae 
have resulted in a rapid accumulation of 
scientific data on their molecular biology, 
epidemiological and clinical features, 
diagnosis as well as treatment.1-4
At the beginning of 2020, one of the 
most significant global health problems 
for humanity is a novel coronavirus 
infection (coronovaris disease 2019 or 
COVID-19), which human population has 
not been previously encountered yet. 
Thus, it was began from an outbreak 
of SARS caused by an unknown type of 
coronavirus, previously called novel 
coronavirus (2019-nCoV) in December 
2019 in the Chinese city of Wuhan.5,6 
Subsequently, genetic analysis showed 
that this novel coronavirus belonged 
to the genus Betacoronavirus and was 
officially renamed as SARS-CoV-2.7 A very 
quick spread of SARS-CoV-2 beyond China 
to all continents (except Antarctica) was 
observed and affected the population 
of developed countries, including the 
United States, Italy, Spain, Germany, 
and France.8 On March 11, 2020, WHO 
declared the COVID-19 as pandemic 
and assessed the event as “public health 
emergency of international concern 
(PHEIC)”.9 During a period of less than 
5 months from the first report of cases 
of new respiratory disease, as of May 6, 
2020, the incidence of COVID-19 in the 
world reached 3,778,016 cases with a 
mortality rate of about 7%, from 4.17 % 
in Germany to 13.8% in Italy.10 According 
to the Center for Public Health (CPH) 
in Ukraine on the same date, 13,184 
cases of COVID-19 were registered, 327 
people died, mostly of respectable age 
with chronic comorbidities (mortality 
2.48%).11
It is important to emphasize that 
SARS-CoV-2 is genetically closely related 
to the original SARS-CoV.5,6 However, no 
effective vaccines and antiviral drugs 
are available at this moment. Given this 
critical situation, the only way to prevent 
the spread of COVID-19 is to impose strict 
quarantine and containment measures 
aimed at isolating patients, contacts and 
virus carriers, social distancing, and the 
use of antiseptics and disinfectants.12
Most studies of COVID-19 epidemic 
modeling started in March 2020 in 
many countries. In particular, such 
modeling was performed on the basis 
of the susceptibility-infected-recovered 
(SIR) model parameterized with the use 
of statistical morbidity and mortality 
data.13,14 Other modeling approaches 
were based on neural networks. Within 
such model, analysts have developed 
two scenarios for the future spread of 
the COVID-19 pandemic. They showed 
that countries with rapid government 
interventions and strict public health 
measures were successful in halting 
the exponential spread of infection.15 
Principle of similarity for COVID-19 
modeling was used in the Center for 
Systems Science and Engineering, 
Johns Hopkins University. It was based 
on statistics of countries with the 
most characteristic manifestations of 
the pandemic.16 However, the above 
studies have an excessive mathematical 
component, some of them introduce 
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conditions and parameters, which are 
difficult to assess in practice. 
The peak incidence of COVID-19 
pandemic in the world has not yet 
passed. It is also not known for how long 
the COVID-19 pandemic will last. WHO 
experts predict a new wave of SARS-
CoV-2 in the second half of 2020. This 
situation fully applies to Ukraine and 
Indonesia. Thus, an extremely important 
and urgent task for the healthcare system 
is to build a prediction of the possible 
further development and features of 
the COVID-19 epidemic process based 
on available (official) epidemiological 
data. Therefore, we would like to 
identify features and develop simple 
epidemic model of COVID-19 on the 
basis of available epidemiological 
data and existing trends in several 
countries (Ukraine and Indonesia) and 
worldwide. The aim was to develop 
simple mathematical model that allows 
calculations in the available information 
packages without loss of quality.
MATERIALS AND METHODS
The scenario of COVID-19 epidemic 
process as an acute respiratory viral 
infection from a mathematical point of 
view is based on the basic epidemiological 
model proposed by W. Kermak and A. 
McKendrick in 1927.17 According to this 
model, individuals in the population can 
be divided into “susceptible” (S), who 
have not previously been exposed to 
SARS-CoV-2, “infectious” (I), who have 
COVID-19 with clinical manifestations, 
and those who recovered or died after 
COVID-19 (R) (FIGURE 1). 
FIGURE 1. Basic epidemiological model of COVID-19
The transition from state S to state I 
represents new cases of COVID-19, and it 
is determined by the force of infection λ 
(rate of SARS-CoV-2 infection). For acute 
infections, the period during which a 
individual is infected (infection period) 
is distributed around some average 
value that can be accurately estimated 
from retrospective epidemiological data. 
Mathematically, this is expressed in the 
probability of transition of individuals 
from state I to state R, which depends on 
how long they were in state I. However, 
epidemiologists often assume that the 
recovery rate γ is a value inverse to the 
average infectious period. The loss of 
acquired immunity over time is reflected 
in the transition from the state R to the 
state S at a rate of ω.
In practice, it is impossible to 
determine such parameters of the 
epidemiological model as the recovery 
rate, the rate of acquired immunity loss, 
as well as the number of people who 
have recovered and acquired immunity. 
Since the purpose of the study was only 
to predict the number of new cases 
(incidence) of COVID-19, this allowed to 
identify a simplified model that describes 
only this process (FIGURE 2).
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FIGURE 2. The incidence model of COVID-19
Mathematically, the incidence 
model of COVID-19 can be described 
by the following equation, according to 
which the number of individuals with 
COVID-19 at each time depends on the 
number of all individuals with COVID-19 
before.
It+1=It+λt St    (1)
where It – the total number of individuals 
with COVID-19 at a given time;
It+1 – the total number of individuals with 
COVID-19 in the next time;
St – the total number of susceptible 
individuals in the population at a given 
time;
The force of the infection λ (rate 
of SARS-CoV-2 infection) depends on 
three different factors: the prevalence 
of infected individuals, the structure of 
population contacts, and probability of 
infection through contact with a sick 
individual:
     
λt=βt It/Nt    (2)
where It – the total number of patients 
with COVID-19 at given time;
Nt – the total number of people in the 
population at given time;
βt – the transmission parameter of the 
SARS-CoV-2 pathogen at given time.
Substitution of formula (2) into 
formula (1) allows to determine 
transmission parameter of SARS-CoV-2 
as the main parameter of the epidemic 
process of COVID-19 at any time on the 
basis of available epidemiological data:
βt=It+1-It/(It/Nt.St)   (3)
Given the fact that It<<Nt, а St ≈ Nt,formula 
(3) can be simplified without loss of 
accuracy:
βt= It+1-It / It    (4)
Without reliable data, we can not 
understand the pandemic. Only based 
on good data can we know how the 
disease is spreading, what impact the 
pandemic has on the live of people 
around the world, and whether the 
counter measures are successful or not. 
However, even the best available data 
on the coronavirus pandemic is far from 
perfect. In the website Our World in 
Data, we found the latest accumulated 
data together with detailed explanations 
of its origin, European Centre for 
Disease Prevention and Control (ECDC). 
To determine initial values of the SARS-
CoV-2 transmission parameter, the daily 
reports COVID-19 cases in Ukraine, 
Indonesia and worlwide were used from 
17 April to 23 May 2020.18
RESULTS AND DISCUSSION
The first step of the study was the 
numerical determination of transmission 
parameter of SARS-CoV-2 according to 
the absolute number of COVID-19 cases 
in Ukraine, Indonesia and worldwide 
that showed its tendency to decrease 
over time and ability of its approximation 
using the exponential function of the 
general form  (FIGURE 3-5).
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FIGURE 3. Numerical determination of SARS-CoV-2 transmission 
parameter by Ukrainian data (β0 = 0.083; β1 = 0.039)
FIGURE 4. Numerical determination of SARS-CoV-2 transmission 
parameter by Indonesian data (β0 = 0.045; β1 = 0.013)
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FIGURE 5. Numerical determination of SARS-CoV-2 transmission 
parameter by global data (β0 = 0.034; β1 = 0.018)
Determination of the analytical type 
of SARS-CoV-2 transmission parameter 
allowed us to make an adequate 
prognosis of COVID-19 incidence in each 
studied region. The modeling results 
showed that by the end of summer 2020, 
above 30 thousand COVID-19 cases are 
expected in Ukraine (FIGURE 6), 100 
thousand COVID-19 cases in Indonesia 
(FIGURE 7) and 12 million COVID-19 
cases worldwide (FIGURE 8).
FIGURE 6. Number of new and total COVID-19 cases in Ukraine 
(real data and modeling)
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FIGURE 7. Number of new and total COVID-19 cases in Indonesia (real data 
and modeling)
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FIGURE 8. Number of new and total COVID-19 cases in the world (real 
data and modeling)
Thus, in our study, we developed 
a simple approach of epidemiological 
modeling of COVID-19 based on evaluation 
of SARS-CoV-2 transmission parameter 
by employing published COVID-19 cases 
for Ukraine, Indonesia, and worldwide. A 
comparative analysis showed the identity 
of modeling results, which further 
testified validity of proposed prediction 
model. It also showed similar trends of 
the epidemic progress of COVID-19 in 
different geographical regions, which 
can be a useful information for future 
decision making. It was found that the 
epidemic progress in Ukraine started 
more intensively than in Indonesia and 
globally, but has been decreasing more 
rapidly. This fact could be explained 
by different temperature conditions, 
dynamics of population movement 
or other factors, that should be paid 
attention to and investigated more 
thoroughly in the future.
Our simple model is fully consistent 
with the principles of mathematical 
epidemiology and studies conducted 
by other scientists on modeling the 
epidemic progress of COVID-19 in other 
regions. Thus, a stochastic model of 
disease spread based on retrospective 
morbidity data in Wuhan was proposed. 
An individual-oriented model of SARS-
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CoV-2 prevalence has been developed to 
identify potential sources of infection. 
Various calculations of the main number 
of reproductions - the average number 
of secondary cases of the disease - were 
analyzed.19,20 Such works are interesting 
analytical studies, but usually have an 
excessive mathematical component, 
difficult numerical calculations, 
and some of them introduce certain 
conditions, such as the number of people 
in the incubation period, which are 
difficult to assess in practice. Although 
our work is based on similar principles, 
it used a simple mathematical model 
that allows calculations in the available 
information packages without loss of 
quality. 
Despite the simplicity of our 
approach, our study has limitations 
because only confirmed COVID-19 
cases with clinical manifestations were 
available, while the facts of asymptomatic 
cases are known.21,22 Nevertheless, this 
was taken into account in the evaluation 
of SARS-CoV-2 transmission parameter, 
suggesting that this parameter already 
took into account involvement of 
asymptomatic individuals into the 
epidemic progress of COVID-19.
CONCLUSION
Predicting the possible consequences 
of the implementation of various health 
care control programs of COVID-19 
involves a comprehensive study of 
the epidemic process of the disease 
as a whole and for certain periods of 
time with the subsequent construction 
of an adequate prediction model. 
We proposed a simple mathematical 
model of COVID-19 epidemic process 
and determined its main transmission 
parameter of SARS-CoV-2, which is a 
complex characteristic of the structure of 
population contacts and the probability 
of infection after contact with a sick 
individual. Our calculations and analysis 
of their results showed that the dynamics 
of SARS-CoV-2 transmission parameter 
is exponentially declining, indicating 
the gradual establishment of endemic 
equilibrium of COVID-19 prevalence 
among the population of Ukraine, 
Indonesia and worldwide in the nearest 
future while maintaining existing trends. 
The developed model is simple, but at 
the same time could be useful as a basis 
for future more complex approaches to 
COVID-19 modeling, taking into account 
various factors, including population 
density, climatic features, number 
of asymptomatic cases and others.
Undoubtedly, our approach will require 
constant updating of data to adjust the 
prediction, taking into account possible 
changes in trends and the influence of 
other factors in the future.
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